US Broker Ratings

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring the Biotech’s Growth Potential Amidst Strong Buy Ratings

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising name in the biotechnology sector, has captured investor attention with its notable market position and potential for innovation. With..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Compelling Biotech Play with 162.70% Potential Upside

For investors seeking opportunities in the biotechnology sector, Structure Therapeutics Inc. (NASDAQ: GPCR) presents an intriguing prospect. With its current market capitalization at $1.61 billion, this..

Neogen Corporation (NEOG) Stock Analysis: Evaluating a 38.65% Potential Upside for Investors

Neogen Corporation (NASDAQ: NEOG) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Founded in 1981 and headquartered in Lansing,..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A Deep Dive into Its 93% Upside Potential

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is a biopharmaceutical company that has caught the attention of investors with promising drug candidates and a staggering potential upside. As..

Arrowhead Pharmaceuticals (ARWR): A Biotechnology Innovator with a 20% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stands out as a notable player in the biotechnology sector, presenting intriguing prospects for investors. With a market capitalization of $5.32..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: 9.42% Potential Upside Amid Strong Revenue Growth

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands out in the biotechnology industry with a significant market cap of $2.48 billion. Renowned for its pioneering work in cellular..

ImmunityBio, Inc. (IBRX) Investor Outlook: A Potential Upside of Over 316% Awaits

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing attention in the biotechnology sector with its innovative approach to harnessing the body’s immune system to combat cancer and infectious..

Vericel Corporation (VCEL): Investor Outlook Highlights 51% Potential Upside

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology industry, has captured the attention of investors with its promising growth trajectory and significant potential upside...

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Balancing Opportunities and Challenges in the Healthcare Sector

Pediatrix Medical Group, Inc. (NYSE: MD), a prominent player in the healthcare sector, specifically within the medical care facilities industry, has garnered investor interest with its..

Innoviva, Inc. (INVA) Stock Analysis: Uncovering a 110% Upside Potential in the Biotechnology Space

For those with a keen eye on the biotechnology sector, Innoviva, Inc. (NASDAQ: INVA) presents a compelling case for investment. With its strategic collaborations and robust..

Select Medical Holdings Corp (SEM): An Investor Outlook on Growth Potential with a 30.53% Upside

Select Medical Holdings Corp. (NYSE: SEM), entrenched in the healthcare sector, specifically the medical care facilities industry, presents a compelling case for investors seeking growth potential...

QuidelOrtho Corporation (QDEL) Stock Analysis: Navigating a 35% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL) stands at a pivotal juncture for investors eyeing opportunities within the healthcare sector. With a market capitalization of $1.97 billion, this San..

Biohaven Ltd. (BHVN) Stock Analysis: Unveiling a Potential 161% Upside in the Biotechnology Sector

Biohaven Ltd. (BHVN), a burgeoning player in the healthcare sector, is capturing the attention of investors with its robust pipeline of innovative therapies and a striking..

GRAIL, Inc. (GRAL) Stock Analysis: A Diagnostic Pioneer with a 91.85 USD Peak Amidst a Potential -38.49% Downside

GRAIL, Inc. (NASDAQ: GRAL) has emerged as a significant player in the healthcare sector, particularly within the diagnostics and research industry. Known for its innovative approach..

Vera Therapeutics, Inc. (VERA): Exploring 107% Potential Upside in Biotechnology

Vera Therapeutics, Inc. (VERA), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to treating serious immunological diseases...

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: A Promising 192% Upside Potential for Investors

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a notable player in the healthcare sector, is capturing investor attention with its unique focus on developing treatments for rare diseases...

Liquidia Corporation (LQDA) Stock Analysis: Exploring a 50.94% Potential Upside in a Booming Biotechnology Sector

Liquidia Corporation (NASDAQ: LQDA) is making waves in the biotechnology sector, capturing investor attention with its robust growth potential. As a company focused on addressing unmet..

National HealthCare Corporation (NHC) Stock Analysis: Exploring Growth Potential with a 28.7% Revenue Surge

National HealthCare Corporation (NHC), a prominent player in the healthcare sector, has garnered attention from investors seeking stability and growth in the medical care facilities industry...

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating a Tough Market with a Unique Growth Proposition

Teladoc Health, Inc. (NYSE: TDOC), a pioneer in virtual healthcare services, stands at a formidable junction as it navigates the challenging health information services sector. With..

Artivion, Inc. (AORT) Stock Analysis: Navigating Growth with a 15.3% Revenue Surge

Artivion, Inc. (NASDAQ: AORT) is capturing investor attention in the healthcare sector with its robust 15.3% revenue growth. Specializing in innovative medical devices and implantable human..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds